Taiwan’s new pregnancy algorithm delivers three critical advances for maternal health research. First, it automates pregnancy identification directly from administrative claims data, eliminating time-consuming manual chart review. Second, it employs hierarchical logic that combines diagnostic codes, procedure records, and laboratory test dates to accurately estimate gestational age without requiring obstetric ultrasound access. Third, it creates a foundation for large-scale drug safety studies across Taiwan’s 23 million insured population.
These capabilities have immediate practical implications for researchers seeking to understand medication safety in pregnancy populations. By leveraging existing health information infrastructure, epidemiologists can now rapidly assemble validated pregnancy cohorts for pharmacovigilance research, accelerating the generation of real-world evidence on maternal medication exposure and outcomes. The approach demonstrates how structured computational methods applied to routine administrative data can strengthen pregnancy-related drug safety monitoring while maintaining efficiency and data security—a model with potential applications beyond Taiwan.
Read the full article on GMJ Newsroom.
Was this article helpful?
